A2i Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 8

A2i Therapeutics General Information

Description

Developer of novel small-molecule immuno-oncology agents designed for the treatment of immuno-oncology diseases. The company's therapeutics are developed by leveraging an artificial intelligence platform to target a key protein in controlling the innate immune response and potentially a key immuno-oncology target, enabling healthcare professionals to combat and treat serious diseases optimally.

Contact Information

Website
www.a2i-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Ilan Ramon
  • Building B, 3rd Floor
  • Ness Ziona 7403635
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 2 Ilan Ramon
  • Building B, 3rd Floor
  • Ness Ziona 7403635
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

A2i Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 18-Dec-2020 Completed Generating Revenue
1. Joint Venture 01-Nov-2020 Completed Generating Revenue
To view A2i Therapeutics’s complete valuation and funding history, request access »

A2i Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

A2i Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025074364-A1 Heterocyclic compounds and uses thereof Inactive 02-Oct-2023

A2i Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Authority Government Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Leaps by Bayer Corporate Venture Capital Minority
OrbiMed Growth/Expansion Minority
RMGLOBAL Healthcare Fund Management Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

A2i Therapeutics FAQs

  • When was A2i Therapeutics founded?

    A2i Therapeutics was founded in 2020.

  • Where is A2i Therapeutics headquartered?

    A2i Therapeutics is headquartered in Ness Ziona, Israel.

  • What industry is A2i Therapeutics in?

    A2i Therapeutics’s primary industry is Drug Discovery.

  • Is A2i Therapeutics a private or public company?

    A2i Therapeutics is a Private company.

  • What is A2i Therapeutics’s current revenue?

    The current revenue for A2i Therapeutics is .

  • Who are A2i Therapeutics’s investors?

    Innovation Authority, Johnson & Johnson JJDC, Leaps by Bayer, OrbiMed, and RMGLOBAL Healthcare Fund Management are 5 of 8 investors who have invested in A2i Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process